Contineum Therapeutics, Inc. CTNM Q3 2025 earnings
Reported October 30, 2025 · Before market open
EPS-$0.45Beat by $0.13
Revenue estimate$5.0M
EPS estimate-$0.58
Next report
Aug 4, 2026 (In 6 days)EPS estimate-$0.46
Versus estimates
Diluted EPS
Ask the moment Contineum Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Contineum Therapeutics, Inc. report Q3 2025 earnings?
- Contineum Therapeutics, Inc. (CTNM) reported Q3 2025 earnings on October 30, 2025 before market open.
- What were Contineum Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- Contineum Therapeutics, Inc. reported eps of $-0.45 for Q3 2025.
- Did Contineum Therapeutics, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.58 by $0.13.
- How did Contineum Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 12.5% from $-0.40.
- Where can I find Contineum Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001437749-25-032427) directly on SEC EDGAR. The filing index links above go to sec.gov.